The leading German index is in a downward trend this year.
(Photo: Bloomberg Creative/Getty Images [M])
Dusseldorf The latest inflation data from the USA give stability to the German stock market. After the new data was published in the afternoon, the leading index Dax was still 0.5 percent lower at 14,123 points and also went out of trading at this point.
In the morning, the sell-off mood still dominated the market. In early trading, the Dax fell by up to two percent and slipped below the 13,900 mark. Investors sold stocks and bonds alike, and the cryptocurrency Bitcoin was not spared either.
Prices in the US rose by 8.5 percent in March compared to the same month last year. This is the highest level since late 1981 and is slightly above market expectations. However, at 6.5 percent, core inflation is 0.1 percentage points below forecasts in advance. Allianz’s chief economic adviser, Mohamed El-Erian, describes this fact as “a great relief for the markets,” as he wrote on Twitter.
Investors on the bond markets initially reacted with relief to the new data: prices rose and, in return, yields fell. Ten-year US bonds returned 2.704 percent after hitting the 2.8 percent threshold in the morning. Two-year bonds returned 2.4321 percent. The yield on ten-year German bonds, which had reached its highest level since 2015 at 0.8 percent, also fell slightly.
Top jobs of the day
Find the best jobs now and
be notified by email.
Yields had increased significantly in the past few weeks. Since they develop inversely to the courses, there was a crash in these papers, which are supposed to be a haven of security. The prices of US bonds with a term of ten years fell from 101 percent to 91.89 percent during this period – a loss of more than nine percent within six weeks. Such a development takes several years at normal times on the bond market.
At the same time, securities with short maturities sometimes yielded higher returns than those with longer ones. That’s unusual because investors typically demand a higher yield the longer they commit, and is thought to portend a recession.
But where is all the money going? The only beneficiaries right now are gold and silver. The price for a troy ounce (31.1 grams) of the yellow precious metal is currently 1973 dollars, silver costs 25.53 dollars. The gold price has thus broken out of its trading range that has existed since mid-March. Gold continues to defy rising bond yields and real interest rates.
“For most of them, the motto ‘Cash is King’ seems to apply at the moment,” says capital market expert Thomas Altmann from asset manager QC Partners. That in turn gives hope. “Given the fact that there are still penalty interest rates for holding cash in the euro zone, this situation should not last for too long.”
Look at individual values
Deutsche Bank/Commerzbank: After the US hedge fund Cerberus, the two German financial institutions are losing another major investor. On Monday evening, the investment bank Morgan Stanley offered two blocks of shares in the two major banks, each of more than five percent, from the same investor. This is Capital Group. The packages should bring a total of 1.75 billion euros.
According to the commissioned bank, 116 million Deutsche Bank shares are to be sold at a price of at least EUR 10.98, which is almost eight percent less than the Xetra closing price on Monday. 72.5 million Commerzbank papers are to be placed for EUR 6.55 each, a good six percent below the closing price. The discount is relatively high, in many cases the discount is five percent.
Accordingly, the price of the two shares slipped significantly. Deutsche Bank shares went down 9.4 percent, Commerzbank shares down 8.5 percent.
Defense stocks: Armor values were again in demand for the individual values. Shares in the Italian armaments group Leonardo rose by up to four percent. Deutsche Bank analysts upgraded the stock to a buy on expectations of higher defense spending in the company’s main markets. Investors also sensed rosy business prospects at Rheinmetall. The titles went out of business with a plus of three percent.
Evotec: The Hamburg biotech company grew significantly last year thanks to higher milestone payments from its partnerships. The stock lost 6.8 percent.
Dermapharm: The Group can look back on the most successful fiscal year in the company’s history. Sales and profit increased significantly. The paper gained 1.7 percent at times, but gave back its gains later on: the title went up 0.3 percent from trading. The drug manufacturer also intends to significantly increase the dividend for the past year. The Board of Management and the Supervisory Board are proposing a dividend of EUR 2.17 (previous year: EUR 0.88) per share.
Here you can go to the page with the Dax course, here you can find the current tops & flops in the Dax.